4 research outputs found
The ethics of ‘Trials within Cohorts’ (TwiCs): 2nd international symposium - London, UK. 7-8 November 2016
On 7-8
th
November 2016, 60 people with an interest in the
‘
Trials
within Cohorts
’
(TwiCs) approach for randomised controlled trial design
met in London. The purpose of this 2
nd
TwiCs international symposium
was to share perspectives and experiences on ethical aspects of the
TwiCs design, discuss how TwiCs relate to the current ethical frame-
work, provide a forum in which to discuss and debate ethical issues
and identify future directions for conceptual and empirical research.
The symposium was supported by the Wellcome Trust and the NIHR
CLAHRC Yorkshire and Humber and organised by members of the
TwiCs network led by Clare Relton and attended by people from the
UK, the Netherlands, Norway, Canada and USA. The two-day sympo-
sium enabled an international group to meet and share experiences
of the TwiCs design (also known as the
‘
cohort multiple RCT design
’
),
and to discuss plans for future research. Over the two days, invited
plenary talks were interspersed by discussions, posters and mini pre-
sentations from bioethicists, triallists and health research regulators.
Key findings of the symposium were: (1) It is possible to make a
compelling case to ethics committees that TwiCs designs are ap-
propriate and ethical; (2) The importance of wider considerations
around the ethics of inefficient trial designs; and (3) some questions
about the ethical requirements for content and timing of informed
consent for a study using the TwiCs design need to be decided on
a case-by-case basis
Inter-observer agreement of MRI-based tumor delineation for preoperative radiotherapy boost in locally advanced rectal cancer
Background While surgery remains the cornerstone of rectal cancer treatment, organ-preservation is upcoming. Therefore, neo-adjuvant treatment should be optimized. By escalating doses, response can be increased. To limit toxicity of boost, accurate gross tumor volume (GTV) definition is required. MRI, especially undeformed fast spin echo diffusion-weighted MRI (DWI), looks promising for delineation. However, inconsistencies between observers should be quantified before clinical implementation. We aim to find which MRI sequence (T2w, DWI or combination) is optimal and clinically useful for GTV definition by evaluating inter-observer agreement. Methods Locally advanced rectal cancer patients (tumors 2). Three independent observers delineated T2w, DWI and combination (Combi) after training-set. Volumes, conformity index (CI), and maximum Hausdorff distance (HD) were calculated between any observer-pair per patient per modality. Results Twenty-four consecutive patients were included. One patient had cT2 (4.2%), 19 cT3 (79.1%) and 4 cT4 (16.7%), with 2 clinical node negative (8.3%), 4 cN1 (16.7%), and 18 cN2 (75.0%) on MRI. From 24 patients, 70 sequences were available (24x T2, 23x DWI, and 23x Combi). Between observers, no significant volume differences were observed per modality. T2 showed significantly largest volumes compared to DWI (mean difference 19.85 ml, SD 17.42, p 0.61). Average HD was largest on T2 (18.60 mm, max 31.40 mm, min 9.20 mm). Discussion Delineation on DWI resulted in delineation of the smallest volumes with similar consistency and mean distances, but with slightly lower Hausdorff distances compared to T2 and Combi. However, with lack of a gold standard it remains difficult to establish if delineations also represent true tumor. Study strengths were DWI adaptation to exclude geometrical distortions and training-set. DWI shows great potential for delineation purposes as long as sufficient experience exists and geometrical distortions are eliminated
Inter-observer agreement of MRI-based tumor delineation for preoperative radiotherapy boost in locally advanced rectal cancer
Background While surgery remains the cornerstone of rectal cancer treatment, organ-preservation is upcoming. Therefore, neo-adjuvant treatment should be optimized. By escalating doses, response can be increased. To limit toxicity of boost, accurate gross tumor volume (GTV) definition is required. MRI, especially undeformed fast spin echo diffusion-weighted MRI (DWI), looks promising for delineation. However, inconsistencies between observers should be quantified before clinical implementation. We aim to find which MRI sequence (T2w, DWI or combination) is optimal and clinically useful for GTV definition by evaluating inter-observer agreement. Methods Locally advanced rectal cancer patients (tumors 2). Three independent observers delineated T2w, DWI and combination (Combi) after training-set. Volumes, conformity index (CI), and maximum Hausdorff distance (HD) were calculated between any observer-pair per patient per modality. Results Twenty-four consecutive patients were included. One patient had cT2 (4.2%), 19 cT3 (79.1%) and 4 cT4 (16.7%), with 2 clinical node negative (8.3%), 4 cN1 (16.7%), and 18 cN2 (75.0%) on MRI. From 24 patients, 70 sequences were available (24x T2, 23x DWI, and 23x Combi). Between observers, no significant volume differences were observed per modality. T2 showed significantly largest volumes compared to DWI (mean difference 19.85 ml, SD 17.42, p 0.61). Average HD was largest on T2 (18.60 mm, max 31.40 mm, min 9.20 mm). Discussion Delineation on DWI resulted in delineation of the smallest volumes with similar consistency and mean distances, but with slightly lower Hausdorff distances compared to T2 and Combi. However, with lack of a gold standard it remains difficult to establish if delineations also represent true tumor. Study strengths were DWI adaptation to exclude geometrical distortions and training-set. DWI shows great potential for delineation purposes as long as sufficient experience exists and geometrical distortions are eliminated